Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.

Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine is more resistant to hydrolysis by cholinesterases, they produce a prolonged depolarization that causes neuromuscular blockade and muscle paralysis. Adding cholinesterase inhibitors further enhances their effects instead of terminating their response, as seen with nondepolarizing blockers.

The effect of depolarizing blockers usually lasts 5-10 minutes. They are often used during an emergency for airway management, endotracheal intubation, or electroconvulsive shock therapy. However, succinylcholine should be avoided for patients with mutated cholinesterases or cholinesterase deficiency, as it can produce more prolonged neuromuscular blockade than desired.

Tags
Depolarizing BlockersMechanism Of ActionSkeletal Muscle FibersNeuromuscular BlockadeSuccinylcholineNicotinic Acetylcholine ReceptorsHydrolysis ResistanceCholinesterase InhibitorsMuscle ParalysisAirway ManagementEndotracheal IntubationElectroconvulsive Shock Therapy

Aus Kapitel 7:

article

Now Playing

7.6 : Depolarizing Blockers: Mechanism of Action

Skeletal Muscle Relaxants

905 Ansichten

article

7.1 : Neuromuskuläre Verbindung und Blockade

Skeletal Muscle Relaxants

2.2K Ansichten

article

7.2 : Klassifizierung von Skelettmuskelrelaxantien

Skeletal Muscle Relaxants

2.2K Ansichten

article

7.3 : Nichtdepolarisierende (kompetitive) neuromuskuläre Blocker: Wirkmechanismus

Skeletal Muscle Relaxants

1.1K Ansichten

article

7.4 : Nichtdepolarisierende (kompetitive) neuromuskuläre Blocker: Pharmakologische Wirkungen

Skeletal Muscle Relaxants

294 Ansichten

article

7.5 : Nichtdepolarisierende (kompetitive) neuromuskuläre Blocker: Pharmakokinetik

Skeletal Muscle Relaxants

382 Ansichten

article

7.7 : Depolarisierende Blocker: Pharmakokinetik

Skeletal Muscle Relaxants

247 Ansichten

article

7.8 : Direkt wirkende Muskelrelaxanzien: Dantrolen und Botulinumtoxin

Skeletal Muscle Relaxants

532 Ansichten

article

7.9 : Skelettmuskelrelaxanzien: Nebenwirkungen

Skeletal Muscle Relaxants

279 Ansichten

article

7.10 : Skelettmuskelrelaxanzien: Therapeutische Anwendungen

Skeletal Muscle Relaxants

398 Ansichten

article

7.11 : Spasmolytische Mittel: Chemische Klassifizierung

Skeletal Muscle Relaxants

805 Ansichten

article

7.12 : Peripher und zentral wirkende Muskelrelaxanzien: Ein Vergleich

Skeletal Muscle Relaxants

2.8K Ansichten

article

7.13 : Zentral wirkende Muskelrelaxanzien: Therapeutische Anwendungen

Skeletal Muscle Relaxants

479 Ansichten

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten